KnowraTardive dyskinesiaLinked fromLinked fromThe 13 pages that link to Tardive dyskinesia, each with the reason it gives.All 13Broader topic 3Related 9Compared with 1AntipsychoticRelated: Long-term dopamine receptor blockade can cause this potentially persistent adverse effect.Dopamine D2 receptorRelated: Long-term D2-blocking treatment is a major risk factor for this movement disorder.MetoclopramideRelated: Long-term metoclopramide exposure can cause this potentially persistent adverse effect.Vesicular monoamine transporter 2Related: VMAT2 inhibitors are established treatments for this disorder.RisperidoneRelated: Long-term risperidone use carries a risk of this potentially persistent adverse effect.ChoreaRelated: Its choreiform movements can resemble chorea, but the medication history and movement pattern help distinguish them.OlanzapineRelated: Like other antipsychotics, olanzapine carries a risk of this potentially persistent complication.QuetiapineRelated: Its risk is lower than with many older antipsychotics but remains relevant during long-term use.FluphenazineRelated: Long-term fluphenazine treatment can carry this risk.